ID27205A - PHARMACY COMPOSITIONS, SUBSTITUTED PHENILAMIDINS CONTAINING THESE COMPOUNDS AND THE PROCESS OF MAKING IT. - Google Patents

PHARMACY COMPOSITIONS, SUBSTITUTED PHENILAMIDINS CONTAINING THESE COMPOUNDS AND THE PROCESS OF MAKING IT.

Info

Publication number
ID27205A
ID27205A IDW20010171A ID20010171A ID27205A ID 27205 A ID27205 A ID 27205A ID W20010171 A IDW20010171 A ID W20010171A ID 20010171 A ID20010171 A ID 20010171A ID 27205 A ID27205 A ID 27205A
Authority
ID
Indonesia
Prior art keywords
phenilamidins
substituted
compounds
making
pharmacy compositions
Prior art date
Application number
IDW20010171A
Other languages
Indonesian (id)
Inventor
Frank Dr Himmelsbach
Brian Dr Guth
Hans-Dieter Schubert
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of ID27205A publication Critical patent/ID27205A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/43Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • C07C211/44Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring
    • C07C211/49Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring having at least two amino groups bound to the carbon skeleton
    • C07C211/50Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to only one six-membered aromatic ring having at least two amino groups bound to the carbon skeleton with at least two amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
IDW20010171A 1998-07-23 1999-07-20 PHARMACY COMPOSITIONS, SUBSTITUTED PHENILAMIDINS CONTAINING THESE COMPOUNDS AND THE PROCESS OF MAKING IT. ID27205A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833105A DE19833105A1 (en) 1998-07-23 1998-07-23 New N-amidinophenyl-1-carboxymethyl-4-piperidinepropanamide derivatives useful as antithrombotic, antiaggregatory, antitumor, antimetastatic, antiinflammatory and anti-osteoporosis agents

Publications (1)

Publication Number Publication Date
ID27205A true ID27205A (en) 2001-03-08

Family

ID=7875009

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20010171A ID27205A (en) 1998-07-23 1999-07-20 PHARMACY COMPOSITIONS, SUBSTITUTED PHENILAMIDINS CONTAINING THESE COMPOUNDS AND THE PROCESS OF MAKING IT.

Country Status (30)

Country Link
EP (1) EP1102746B1 (en)
JP (1) JP3629208B2 (en)
KR (1) KR20010072046A (en)
CN (1) CN1310708A (en)
AR (1) AR019462A1 (en)
AT (1) ATE240297T1 (en)
AU (1) AU5285399A (en)
BG (1) BG105159A (en)
BR (1) BR9912321A (en)
CA (1) CA2337413A1 (en)
CO (1) CO5080745A1 (en)
DE (2) DE19833105A1 (en)
DK (1) DK1102746T3 (en)
EA (1) EA200100106A1 (en)
EE (1) EE200100048A (en)
ES (1) ES2199587T3 (en)
HK (1) HK1038750A1 (en)
HU (1) HUP0103327A3 (en)
ID (1) ID27205A (en)
IL (1) IL140774A0 (en)
NO (1) NO20010354D0 (en)
PL (1) PL345624A1 (en)
PT (1) PT1102746E (en)
SK (1) SK1052001A3 (en)
TR (1) TR200100182T2 (en)
TW (1) TW460461B (en)
UY (1) UY25621A1 (en)
WO (1) WO2000005207A1 (en)
YU (1) YU3701A (en)
ZA (1) ZA200100363B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10002510A1 (en) 2000-01-21 2001-07-26 Boehringer Ingelheim Pharma New phenylamidine compounds are useful for the treatment of thrombosis, cerebrovascular disorders, heart infarction, arteriosclerosis, osteoporosis, tumor metastasis, shock and diabetes
US8399678B2 (en) * 2009-11-18 2013-03-19 Boehringer Ingelheim International Gmbh Process for the manufacture of dabigatran etexilate
EP2522662A1 (en) 2011-05-11 2012-11-14 Medichem, S.A. Dabigatran etexilate and related substances, processes and compositions, and use of the substances as reference standards and markers
CN105330568B (en) * 2015-11-27 2017-05-10 山东省医学科学院药物研究所 Preparation method for p-aminobenzamidine hydrochloride
CN105732433A (en) * 2016-04-13 2016-07-06 山东新华制药股份有限公司 Refining method of Dabigatran etexilate intermediate condensation compound

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5877174A (en) * 1994-12-01 1999-03-02 Toyama Chemical Co., Ltd. 2,3-diketopiperazine derivatives or their salts
DE19515500A1 (en) * 1995-04-27 1996-10-31 Thomae Gmbh Dr K Substituted phenylamidines, pharmaceutical compositions containing these compounds and processes for their preparation

Also Published As

Publication number Publication date
HUP0103327A2 (en) 2002-01-28
EP1102746B1 (en) 2003-05-14
TR200100182T2 (en) 2001-07-23
NO20010354L (en) 2001-01-22
UY25621A1 (en) 2001-12-28
KR20010072046A (en) 2001-07-31
CA2337413A1 (en) 2000-02-03
SK1052001A3 (en) 2001-08-06
ZA200100363B (en) 2001-07-18
EP1102746A1 (en) 2001-05-30
JP2002521363A (en) 2002-07-16
YU3701A (en) 2003-01-31
CO5080745A1 (en) 2001-09-25
WO2000005207A1 (en) 2000-02-03
NO20010354D0 (en) 2001-01-22
ATE240297T1 (en) 2003-05-15
BR9912321A (en) 2001-04-24
EA200100106A1 (en) 2001-08-27
DE59905568D1 (en) 2003-06-18
CN1310708A (en) 2001-08-29
IL140774A0 (en) 2002-02-10
ES2199587T3 (en) 2004-02-16
TW460461B (en) 2001-10-21
EE200100048A (en) 2002-06-17
JP3629208B2 (en) 2005-03-16
AU5285399A (en) 2000-02-14
BG105159A (en) 2001-07-31
AR019462A1 (en) 2002-02-20
PT1102746E (en) 2003-10-31
DK1102746T3 (en) 2003-09-08
PL345624A1 (en) 2002-01-02
DE19833105A1 (en) 2000-01-27
HUP0103327A3 (en) 2003-11-28
HK1038750A1 (en) 2002-03-28

Similar Documents

Publication Publication Date Title
ID24929A (en) DURUNAN 2-ARIL-8-OXYODIHYDRROPURIN, THE PROCESS OF MAKING IT, THE COMPOSITION OF THE PHARMACY THAT CONTAINS IT, AND ITS COMPOUND
ID30299A (en) OKSAZOLIDINON DERIVES, THE PROCESS OF MAKING IT AND THE PHARMACY COMPOSITION THAT CONTAINS IT
MXPA00007681A (en) Compositions containing organic compounds.
ID18046A (en) COMPOUND, MIXED CYCLE, MANUFACTURE AND USE OF IT.
ID16128A (en) NEW ARILGLICINAMIDE DEPOSITS, THE PROCESS OF MAKING AND PHARMACY COMPOSITION THAT CONTAINS THIS COMPOUND
BR9915515B1 (en) curable composition of multicomponents.
ZA9810125B (en) Chemical compounds.
DE69802615T2 (en) Triaromatic compounds, compositions containing them and their uses
ZA993364B (en) Novel 4-phenylpiperidines for the treatment of pruritic dermatoses.
ID23436A (en) ACRILONITRIL COMPOUNDS, PROCESSES FOR ITS PRODUCTS AND THE PESTICIDES CONTAINING IT
ID26102A (en) THE PROCESS OF MAKING STILBENA COMPOUNDS
ID17810A (en) NEW SUBSTITUTED 2,4-TIAZOLIDINDION DOCUMENTS, PROCESSES FOR THE PRODUCTION AND PHARMACY COMPOSITION WHICH CONTAINS IT
ID20137A (en) PROPANOLAMINA DECREASED, THE PROCESS OF MAKING, PHARMACEUTICAL PROPERTIES THAT CONTAIN THIS COMPOUND, AND ITS USE
ID29295A (en) PYRIMIDINONE COMPOUNDS, PHARMACEUTICAL COMPOSITION THAT CONTAINS THE COMPOUND AND THE PROCESS OF SUPPLYING THE COMPOUND
ZA200005510B (en) Pharmaceutical composition.
ID22911A (en) NEW TRIAZOL DISTRICTS, THE PROCESS OF MAKING AND THE PHARMACY COMPOSITION CONTAINING IT
IS2296B (en) Process for the preparation of protected 4-aminomethyl-pyrrolidin-3-one.
TR199903132A3 (en) Activating composition of metallocane compounds.
ID24173A (en) 1,2,3,4,5,6 HEKSAHIDRO-2-6-METANO-3-BENZAZOSIN-10-OL, THE PROCESS OF MAKING AND USING IT FOR MEDICINES
BR9903981B1 (en) methylcyclotetradec-5-en-1-ones fragrance compounds and compositions.
ID27205A (en) PHARMACY COMPOSITIONS, SUBSTITUTED PHENILAMIDINS CONTAINING THESE COMPOUNDS AND THE PROCESS OF MAKING IT.
ID23784A (en) THE PROCESS OF THE MAKING OF THE ALKOXSIFURAMAMINA DOWN, THE COMPOUND OBTAINED BY THIS PROCESS, AND THE USE OF THESE COMPOUNDS.
ZA9810063B (en) Process for the manufacture of an organic compound.
ID29871A (en) NEW MORFOLIN DISTRICTS, THE METHOD OF MAKING IT AND THE PHARMACY COMPOSITION THAT CONTAINS IT
ID21968A (en) 11-ACETYL-12, 13-DIOXABICICLO (8.2.1) -TRIDESENONE, THE PROCESS OF MAKING IT AND THE COMPOUNDS USED AS A MEDICINE